Natural compounds from saffron and bear bile prevent vision loss and retinal degeneration

Molecules

Volumn 20, Issue 8, 2015, Pages 13875-13893

  Fernández Sánchez, Laura ^a   Lax, Pedro ^a   Noailles, Agustina ^a   Angulo, Antonia ^a   Maneu, Victoria ^a   Cuenca, Nicolás ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Apoptosis; Crocus sativus; Oxidative stress; P23H; Retina; Safranal; Tauroursodeoxycholic acid; TUDCA

Indexed keywords

BIOLOGICAL PRODUCT; NEUROPROTECTIVE AGENT;

ANIMAL; BEAR; BILE; BLINDNESS; CHEMISTRY; CROCUS; RETINAL DEGENERATION;

ANIMALS; BILE; BIOLOGICAL PRODUCTS; BLINDNESS; CROCUS; NEUROPROTECTIVE AGENTS; RETINAL DEGENERATION; URSIDAE;

EID: 84941248324     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules200813875     Document Type: Review

References (123)

1. Cuenca, N.; Fernandez-Sanchez, L.; Campello, L.; Maneu, V.; de la Villa, P.; Lax, P.; Pinilla, I. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog. Retin. Eye Res. 2014, 43, 17-75.
2. Stone, J.; van Driel, D.; Valter, K.; Rees, S.; Provis, J. The locations of mitochondria in mammalian photoreceptors: Relation to retinal vasculature. Brain Res. 2008, 1189, 58-69.
3. Szikra, T.; Krizaj, D. Intracellular organelles and calcium homeostasis in rods and cones. Vis. Neurosci. 2007, 24, 733-743.
4. Panfoli, I.; Calzia, D.; Bianchini, P.; Ravera, S.; Diaspro, A.; Candiano, G.; Bachi, A.; Monticone, M.; Aluigi, M.G.; Barabino, S.; et al. Evidence for aerobic metabolism in retinal rod outer segment disks. Int. J. Biochem. Cell Biol. 2009, 41, 2555-2565.
5. Panfoli, I.; Calzia, D.; Ravera, S.; Morelli, A.M.; Traverso, C.E. Extra-mitochondrial aerobic metabolism in retinal rod outer segments: New perspectives in retinopathies. Med. Hypotheses 2012, 78, 423-427.
6. Johnson, J.E., Jr.; Perkins, G.A.; Giddabasappa, A.; Chaney, S.; Xiao, W.; White, A.D.; Brown, J.M.; Waggoner, J.; Ellisman, M.H.; Fox, D.A. Spatiotemporal regulation of ATP and Ca2+ dynamics in vertebrate rod and cone ribbon synapses. Mol. Vis. 2007, 13, 887-919.
7. Nicholls, D.G.; Johnson-Cadwell, L.; Vesce, S.; Jekabsons, M.; Yadava, N. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J. Neurosci. Res. 2007, 85, 3206-3212.
8. Yadava, N.; Nicholls, D.G. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J. Neurosci. 2007, 27, 7310-7317.
9. Tomany, S.C.; Wang, J.J.; van Leeuwen, R.; Klein, R.; Mitchell, P.; Vingerling, J.R.; Klein, B.E.; Smith, W.; de Jong, P.T. Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology 2004, 111, 1280-1287.
10. Khan, J.C.; Thurlby, D.A.; Shahid, H.; Clayton, D.G.; Yates, J.R.; Bradley, M.; Moore, A.T.; Bird, A.C. Smoking and age related macular degeneration: The number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br. J. Ophthalmol. 2006, 90, 75-80.
11. Sanvicens, N.; Gomez-Vicente, V.; Masip, I.; Messeguer, A.; Cotter, T.G. Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. J. Biol. Chem. 2004, 279, 39268-39278.
12. Chrysostomou, V.; Rezania, F.; Trounce, I.A.; Crowston, J.G. Oxidative stress and mitochondrial dysfunction in glaucoma. Curr. Opin. Pharmacol. 2013, 13, 12-15.
13. Himori, N.; Yamamoto, K.; Maruyama, K.; Ryu, M.; Taguchi, K.; Yamamoto, M.; Nakazawa, T. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death. J. Neurochem. 2013, 127, 669-680.
14. Kowluru, R.A.; Tang, J.; Kern, T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001, 50, 1938-1942.
15. Shanab, A.Y.; Nakazawa, T.; Ryu, M.; Tanaka, Y.; Himori, N.; Taguchi, K.; Yasuda, M.; Watanabe, R.; Takano, J.; Saido, T.; et al. Metabolic stress response implicated in diabetic retinopathy: The role of calpain, and the therapeutic impact of calpain inhibitor. Neurobiol. Dis. 2012, 48, 556-567.
16. Du, Y.; Miller, C.M.; Kern, T.S. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic. Biol. Med. 2003, 35, 1491-1499.
17. Du, Y.; Cramer, M.; Lee, C.A.; Tang, J.; Muthusamy, A.; Antonetti, D.A.; Jin, H.; Palczewski, K.; Kern, T.S. Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: Relationship to capillary degeneration and permeability. FASEB J. 2015, 29, 2194-2204.
18. Muller, F.L.; Liu, Y.; van Remmen, H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 2004, 279, 49064-49073.
19. Murakami, Y.; Notomi, S.; Hisatomi, T.; Nakazawa, T.; Ishibashi, T.; Miller, J.W.; Vavvas, D.G. Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog. Retin. Eye Res. 2013, 37, 114-140.
20. Strasser, A.; O'Connor, L.; Dixit, V.M. Apoptosis signaling. Annu. Rev. Biochem. 2000, 69, 217-245.
21. Kuan, C.Y.; Roth, K.A.; Flavell, R.A.; Rakic, P. Mechanisms of programmed cell death in the developing brain. Trends Neurosci. 2000, 23, 291-297.
22. Fong, W.G.; Tsilfidis, C. Retinal degeneration and cellular suicide. Adv. Exp. Med. Biol. 2012, 723, 207-214.
23. Sancho-Pelluz, J.; Arango-Gonzalez, B.; Kustermann, S.; Romero, F.J.; van Veen, T.; Zrenner, E.; Ekstrom, P.; Paquet-Durand, F. Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol. Neurobiol. 2008, 38, 253-269.
24. Arango-Gonzalez, B.; Trifunovic, D.; Sahaboglu, A.; Kranz, K.; Michalakis, S.; Farinelli, P.; Koch, S.; Koch, F.; Cottet, S.; Janssen-Bienhold, U.; et al. Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration. PLoS ONE 2014, 9, e112142.
25. Kaur, J.; Mencl, S.; Sahaboglu, A.; Farinelli, P.; van Veen, T.; Zrenner, E.; Ekstrom, P.; Paquet-Durand, F.; Arango-Gonzalez, B. Calpain and PARP activation during photoreceptor cell death in P23H and S334ter rhodopsin mutant rats. PLoS ONE 2011, 6, e22181.
26. Wong, P. Apoptosis, retinitis pigmentosa, and degeneration. Biochem. Cell Biol. 1994, 72, 489-498.
27. Portera-Cailliau, C.; Sung, C.H.; Nathans, J.; Adler, R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 1994, 91, 974-978.
28. Doonan, F.; Donovan, M.; Cotter, T.G. Activation of multiple pathways during photoreceptor apoptosis in the rd mouse. Investig. Ophthalmol. Vis. Sci. 2005, 46, 3530-3538.
29. Daiger, S. P. RetNet. Available online: https://sph.uth.edu/retnet/disease.htm (accessed on 28 July 2015).
30. Dryja, T.P.; McGee, T.L.; Reichel, E.; Hahn, L.B.; Cowley, G.S.; Yandell, D.W.; Sandberg, M.A.; Berson, E.L. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990, 343, 364-366.
31. Dryja, T.P.; McEvoy, J.A.; McGee, T.L.; Berson, E.L. Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa. Investig. Ophthalmol. Vis. Sci. 2000, 41, 3124-3127.
32. Kaushal, S.; Khorana, H.G. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 1994, 33, 6121-6128.
33. Illing, M.E.; Rajan, R.S.; Bence, N.F.; Kopito, R.R. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 2002, 277, 34150-34160.
34. Reme, C.E.; Grimm, C.; Hafezi, F.; Marti, A.; Wenzel, A. Apoptotic cell death in retinal degenerations. Prog. Retin. Eye Res. 1998, 17, 443-464.
35. Machida, S.; Kondo, M.; Jamison, J.A.; Khan, N.W.; Kononen, L.T.; Sugawara, T.; Bush, R.A.; Sieving, P.A. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Investig. Ophthalmol. Vis. Sci. 2000, 41, 3200-3209.
36. Berson, E.L.; Rosner, B.; Sandberg, M.A.; Dryja, T.P. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch. Ophthalmol. 1991, 109, 92-101.
37. Cuenca, N.; Pinilla, I.; Sauve, Y.; Lu, B.; Wang, S.; Lund, R.D. Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience 2004, 127, 301-317.
38. Garcia-Ayuso, D.; Salinas-Navarro, M.; Agudo, M.; Cuenca, N.; Pinilla, I.; Vidal-Sanz, M.; Villegas-Perez, M.P. Retinal ganglion cell numbers and delayed retinal ganglion cell death in the P23H rat retina. Exp. Eye Res. 2010, 91, 800-810.
39. Kolomiets, B.; Dubus, E.; Simonutti, M.; Rosolen, S.; Sahel, J.A.; Picaud, S. Late histological and functional changes in the P23H rat retina after photoreceptor loss. Neurobiol. Dis. 2010, 38, 47-58.
40. Esquiva, G.; Lax, P.; Cuenca, N. Impairment of intrinsically photosensitive retinal ganglion cells associated with late stages of retinal degeneration. Investig. Ophthalmol. Vis. Sci. 2013, 54, 4605-4618.
41. Fernandez-Sanchez, L.; Lax, P.; Pinilla, I.; Martin-Nieto, J.; Cuenca, N. Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. Investig. Ophthalmol. Vis. Sci.2011, 52, 4998-5008.
42. Fernandez-Sanchez, L.; Lax, P.; Esquiva, G.; Martin-Nieto, J.; Pinilla, I.; Cuenca, N. Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats. PLoS ONE 2012, 7, e43074.
43. Fernandez-Sanchez, L.; Lax, P.; Isiegas, C.; Ayuso, E.; Ruiz, J.M.; de la Villa, P.; Bosch, F.; de la Rosa, E.J.; Cuenca, N. Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa. Hum. Gene Ther. 2012, 23, 1290-1300.
44. Lax, P.; Esquiva, G.; Altavilla, C.; Cuenca, N. Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration. Exp. Eye Res. 2014, 120, 175-185.
45. Javadi, B.; Sahebkar, A.; Emami, S.A. A survey on saffron in major islamic traditional medicine books. Iran. J. Basic Med. Sci. 2013, 16, 1-11.
46. Hosseinzadeh, H.; Nassiri-Asl, M. Avicenna's (Ibn Sina) the Canon of Medicine and saffron (Crocus sativus): A review. Phytother. Res. 2013, 27, 475-483.
47. Abdullaev, F.I. Biological effects of saffron. Biofactors 1993, 4, 83-86.
48. Bolhassani, A.; Khavari, A.; Bathaie, S.Z. Saffron and natural carotenoids: Biochemical activities and anti-tumor effects. Biochim. Biophys. Acta 2014, 1845, 20-30.
49. Bisti, S.; Maccarone, R.; Falsini, B. Saffron and retina: Neuroprotection and pharmacokinetics. Vis. Neurosci. 2014, 31, 355-361.
50. Falsini, B.; Piccardi, M.; Minnella, A.; Savastano, C.; Capoluongo, E.; Fadda, A.; Balestrazzi, E.; Maccarone, R.; Bisti, S. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2010, 51, 6118-6124.
51. Maccarone, R.; di Marco, S.; Bisti, S. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Investig. Ophthalmol. Vis. Sci. 2008, 49, 1254-1261.
52. Natoli, R.; Zhu, Y.; Valter, K.; Bisti, S.; Eells, J.; Stone, J. Gene and noncoding RNA regulation underlying photoreceptor protection: microarray study of dietary antioxidant saffron and photobiomodulation in rat retina. Mol. Vis. 2010, 16, 1801-1822.
53. Marco, F.D.; Romeo, S.; Nandasena, C.; Purushothuman, S.; Adams, C.; Bisti, S.; Stone, J. The time course of action of two neuroprotectants, dietary saffron and photobiomodulation, assessed in the rat retina. Am. J. Neurodegener. Dis. 2013, 2, 208-220.
54. Li, N.; Lin, G.; Kwan, Y.W.; Min, Z.D. Simultaneous quantification of five major biologically active ingredients of saffron by high-performance liquid chromatography. J. Chromatogr. A 1999, 849, 349-355.
55. Yamauchi, M.; Tsuruma, K.; Imai, S.; Nakanishi, T.; Umigai, N.; Shimazawa, M.; Hara, H. Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur. J. Pharmacol. 2011, 650, 110-119.
56. Ishizuka, F.; Shimazawa, M.; Umigai, N.; Ogishima, H.; Nakamura, S.; Tsuruma, K.; Hara, H. Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice. Eur. J. Pharmacol. 2013, 703, 1-10.
57. Ohno, Y.; Nakanishi, T.; Umigai, N.; Tsuruma, K.; Shimazawa, M.; Hara, H. Oral administration of crocetin prevents inner retinal damage induced by N-methyl-D-aspartate in mice. Eur. J. Pharmacol. 2012, 690, 84-89.
58. Laabich, A.; Vissvesvaran, G.P.; Lieu, K.L.; Murata, K.; McGinn, T.E.; Manmoto, C.C.; Sinclair, J.R.; Karliga, I.; Leung, D.W.; Fawzi, A.; et al. Protective effect of crocin against blue light- and white light-mediated photoreceptor cell death in bovine and primate retinal primary cell culture. Investig. Ophthalmol. Vis. Sci. 2006, 47, 3156-3163.
59. Xuan, B.; Zhou, Y.H.; Li, N.; Min, Z.D.; Chiou, G.C. Effects of crocin analogs on ocular blood flow and retinal function. J. Ocul. Pharmacol. Ther. 1999, 15, 143-152.
60. Qi, Y.; Chen, L.; Zhang, L.; Liu, W.B.; Chen, X.Y.; Yang, X.G. Crocin prevents retinal ischaemia/reperfusion injury-induced apoptosis in retinal ganglion cells through the PI3K/AKT signalling pathway. Exp. Eye Res. 2013, 107, 44-51.
61. Farahmand, S.K.; Samini, F.; Samini, M.; Samarghandian, S. Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver. Biogerontology 2013, 14, 63-71.
62. Hosseinzadeh, H.; Modaghegh, M.H.; Saffari, Z. Crocus sativus L. (Saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle. Evid. Based Complement. Altern. Med. 2009, 6, 343-350.
63. Hosseinzadeh, H.; Sadeghnia, H.R. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J. Pharm. Pharm. Sci. 2005, 8, 394-399.
64. Boatright, J.H.; Moring, A.G.; McElroy, C.; Phillips, M.J.; Do, V.T.; Chang, B.; Hawes, N.L.; Boyd, A.P.; Sidney, S.S.; Stewart, R.E.; et al. Tool from ancient pharmacopoeia prevents vision loss. Mol. Vis. 2006, 12, 1706-1714.
65. Phillips, M.J.; Walker, T.A.; Choi, H.Y.; Faulkner, A.E.; Kim, M.K.; Sidney, S.S.; Boyd, A.P.; Nickerson, J.M.; Boatright, J.H.; Pardue, M.T. Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30. Investig. Ophthalmol. Vis. Sci. 2008, 49, 2148-2155.
66. Boatright, J.H.; Nickerson, J.M.; Moring, A.G.; Pardue, M.T. Bile acids in treatment of ocular disease. J. Ocul. Biol. Dis. Infor. 2009, 2, 149-159.
67. Oveson, B.C.; Iwase, T.; Hackett, S.F.; Lee, S.Y.; Usui, S.; Sedlak, T.W.; Snyder, S.H.; Campochiaro, P.A.; Sung, J.U. Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. J. Neurochem. 2011, 116, 144-153.
68. Drack, A.V.; Dumitrescu, A.V.; Bhattarai, S.; Gratie, D.; Stone, E.M.; Mullins, R.; Sheffield, V.C. TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice. Investig. Ophthalmol. Vis. Sci. 2012, 53, 100-106.
69. Woo, S.J.; Kim, J.H.; Yu, H.G. Ursodeoxycholic acid and tauroursodeoxycholic acid suppress choroidal neovascularization in a laser-treated rat model. J. Ocul. Pharmacol. Ther. 2010, 26, 223-229.
70. Mantopoulos, D.; Murakami, Y.; Comander, J.; Thanos, A.; Roh, M.; Miller, J.W.; Vavvas, D.G. Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment. PLoS ONE 2011, 6, e24245.
71. Gaspar, J.M.; Martins, A.; Cruz, R.; Rodrigues, C.M.; Ambrosio, A.F.; Santiago, A.R. Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose. Neuroscience 2013, 253, 380-388.
72. Zhang, T.; Baehr, W.; Fu, Y. Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis. Investig. Ophthalmol. Vis. Sci. 2012, 53, 3349-3356.
73. Langmann, T. Microglia activation in retinal degeneration. J. Leukoc. Biol. 2007, 81, 1345-1351.
74. Noailles, A.; Fernandez-Sanchez, L.; Lax, P.; Cuenca, N. Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects. J. Neuroinflamm. 2014, 11, doi:10.1186/s12974-014-0186-3.
75. Polazzi, E.; Monti, B. Microglia and neuroprotection: From in vitro studies to therapeutic applications. Prog. Neurobiol. 2010, 92, 293-315.
76. Cunningham, C. Microglia and neurodegeneration: The role of systemic inflammation. Glia 2013, 61, 71-90.
77. Reus, G.Z.; Fries, G.R.; Stertz, L.; Badawy, M.; Passos, I.C.; Barichello, T.; Kapczinski, F.; Quevedo, J. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience 2015, 300, 141-154.
78. Jebelli, J.; Su, W.; Hopkins, S.; Pocock, J.; Garden, G.A. Glia: Guardians, gluttons, or guides for the maintenance of neuronal connectivity? Ann. N. Y. Acad. Sci. 2015, doi:10.1111/nyas.12711.
79. Sanchez-Guajardo, V.; Tentillier, N.; Romero-Ramos, M. The relation between alpha-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience 2015, doi:10.1016/j.neuroscience.2015.02.008.
80. Lam, T.T.; Kwong, J.M.; Tso, M.O. Early glial responses after acute elevated intraocular pressure in rats. Investig. Ophthalmol. Vis. Sci. 2003, 44, 638-645.
81. Bosco, A.; Steele, M.R.; Vetter, M.L. Early microglia activation in a mouse model of chronic glaucoma. J. Comp. Neurol. 2011, 519, 599-620.
82. Penfold, P.L.; Madigan, M.C.; Gillies, M.C.; Provis, J.M. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 2001, 20, 385-414.
83. Buschini, E.; Piras, A.; Nuzzi, R.; Vercelli, A. Age related macular degeneration and drusen: Neuroinflammation in the retina. Prog. Neurobiol. 2011, 95, 14-25.
84. Ng, T.F.; Streilein, J.W. Light-induced migration of retinal microglia into the subretinal space. Investig. Ophthalmol. Vis. Sci. 2001, 42, 3301-3310.
85. Zhang, C.; Shen, J.K.; Lam, T.T.; Zeng, H.Y.; Chiang, S.K.; Yang, F.; Tso, M.O. Activation of microglia and chemokines in light-induced retinal degeneration. Mol. Vis. 2005, 11, 887-895.
86. Gupta, N.; Brown, K.E.; Milam, A.H. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp. Eye Res. 2003, 76, 463-471.
87. Yoshida, N.; Ikeda, Y.; Notomi, S.; Ishikawa, K.; Murakami, Y.; Hisatomi, T.; Enaida, H.; Ishibashi, T. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 2013, 120, e5-e12.
88. Peng, B.; Xiao, J.; Wang, K.; So, K.F.; Tipoe, G.L.; Lin, B. Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa. J. Neurosci. 2014, 34, 8139-8150.
89. Yang, P.; de Vos, A.F.; Kijlstra, A. Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Investig. Ophthalmol. Vis. Sci. 1996, 37, 77-85.
90. Yanguas-Casas, N.; Barreda-Manso, M.A.; Nieto-Sampedro, M.; Romero-Ramirez, L. Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. J. Neuroinflamm. 2014, 11, doi:10.1186/1742-2094-11-50.
91. Park, J.; Choi, H.; Min, J.S.; Park, S.J.; Kim, J.H.; Park, H.J.; Kim, B.; Chae, J.I.; Yim, M.; Lee, D.S. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J. Neurochem. 2013, 127, 221-232.
92. Yang, L.P.; Wu, L.M.; Guo, X.J.; Tso, M.O.M. Activation of endoplasmic reticulum stress in degenerating photoreceptors of the rd1 mouse. Investig. Ophthalmol. Vis. Sci. 2007, 48, 5191-5198.
93. Sizova, O.S.; Shinde, V.M.; Lenox, A.R.; Gorbatyuk, M.S. Modulation of cellular signaling pathways in P23H rhodopsin photoreceptors. Cell. Signal. 2014, 26, 665-672.
94. Sanges, D.; Marigo, V. Cross-talk between two apoptotic pathways activated by endoplasmic reticulum stress: Differential contribution of caspase-12 and AIF. Apoptosis 2006, 11, 1629-1641.
95. Suzuki, K.; Hata, S.; Kawabata, Y.; Sorimachi, H. Structure, activation, and biology of calpain. Diabetes 2004, 53 (Suppl. 1), S12-S18.
96. Nguyen, A.T. H.; Campbell, M.; Kenna, P.F.; Kiang, A.S.; Tam, L.; Humphries, M.M.; Humphries, P. Calpain and Photoreceptor Apoptosis. Retin. Degener. Dis. 2012, 723, 547-552.
97. Tan, Y.; Dourdin, N.; Wu, C.; Veyra, T.D.; Elce, J.S.; Peter, A.; Greer, P.A. Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem. 2006, 281, 16016-16024.
98. Paquet-Durand, F.; Azadi, S.; Hauck, S.M.; Ueffing, M.; van Veen, T.; Ekstrom, P. Calpain is activated in degenerating photoreceptors in the rd1 mouse. J. Neurochem. 2006, 96, 802-814.
99. Ozaki, T.; Nakazawa, M.; Yamashita, T.; Sorimachi, H.; Hata, S.; Tomita, H.; Isago, H.; Baba, A.; Ishiguro, S.I. Intravitreal injection or topical eye-drop application of a μ-calpain C2L domain peptide protects against photoreceptor cell death in Royal College of Surgeons' rats, a model of retinitis pigmentosa. Biochim. Biophys. Acta 2012, 1822, 1783-1795.
100. Keeble, J.A.; Gilmore, A.P. Apoptosis commitment-Translating survival signals into decisions on mitochondria. Cell Res. 2007, 17, 976-984.
101. Kunte, M.M.; Choudhury, S.; Manheim, J.F.; Shinde, V.M.; Miura, M.; Chiodo, V.A.; Hauswirth, W.W.; Gorbatyuk, O.S.; Gorbatyuk, M.S. ER stress is involved in T17M rhodopsin-induced retinal degeneration. Investig. Ophthalmol. Vis. Sci. 2012, 53, 3792-3800.
102. Garrido, C.; Galluzzi, L.; Brunet, M.; Puig, P.E.; Didelot, C.; Kroemer, G. Mechanisms of cytochrome c release from mitochondria. Cell Death Diff. 2006, 13, 1423-1433.
103. Tait, S.W.G.; Green, D.R. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 2010, 11, 621-632.
104. Sanvicens, N.; Cotter, T.G. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J. Neurochem. 2006, 98, 1432-1444.
105. Boya, P.; Kroemer, G. Lysosomal membrane permeabilization in cell death. Oncogene 2008, 27, 6434-6451.
106. Chahory, S.; Keller, N.; Martin, E.; Omri, B.; Crisanti, P.; Torriglia, A. Light induced retinal degeneration activates a caspase-independent pathway involving cathepsin D. Neurochem. Int. 2010, 57, 278-287.
107. Metrailler, S.; Schorderet, D.F.; Cottet, S. Early apoptosis of rod photoreceptors in Rpe65-/- mice is associated with the upregulated expression of lysosomal-mediated autophagic genes. Exp. Eye Res. 2012, 96, 70-81.
108. Assimopoulou, N.; Sinakos, Z.; Papageorgiou, V.P. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother. Res. 2005, 19, 997-1000.
109. Kanakis, C.D.; Tarantilis, P.A.; Tajmir-Riahi, H.A.; Polissiou, M.G. DNA interaction with saffron's secondary metabolites safranal, crocetin, and dimethylcrocetin. DNA Cell Biol. 2007, 26, 63-70.
110. Kanakis, C.D.; Tarantilis, P.A.; Pappas, C.; Bariyanga, J.; Tajmir-Riahi, H.A.; Polissiou, M.G. An overview of structural features of DNA and RNA complexes with saffron compounds: Models and antioxidant activity. J. Photochem. Photobiol. B 2009, 95, 204-212.
111. Kirkegaard, T.; Jaattela, M. Lysosomal involvement in cell death and cancer. Biochim. Biophys. Acta 2009, 1793, 746-754.
112. Bharti, S.; Golechha, M.; Kumari, S.; Siddiqui, K.M.; Arya, D.S. Akt/GSK-3beta/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia-reperfusion injury in rats. Eur. J. Nutr. 2012, 51, 719-727.
113. Ramalho, R.M.; Viana, R.J. S.; Low, W.C.; Steer, C.J.; Rodrigues, C.M. P. Bile acids and apoptosis modulation: An emerging role in experimental Alzheimer's disease. Trends Mol. Med. 2008, 14, 54-62.
114. Amaral, J.D.; Viana, R.J. S.; Ramalho, R.M.; Steer, C.J.; Rodrigues, C.M. P. Bile acids: Regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 2009, 50, 1721-1734.
115. Nunes, A.F.; Amaral, J.D.; Lo, A.C.; Fonseca, M.B.; Viana, R.J.; Callaerts-Vegh, Z.; D'Hooge, R.; Rodrigues, C.M. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-beta deposition in APP/PS1 mice. Mol. Neurobiol. 2012, 45, 440-454.
116. Sola, S.; Castro, R.E.; Laires, P.A.; Steer, C.J.; Rodrigues, C.M. Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. Mol. Med. 2003, 9, 226-234.
117. Rodrigues, C.M.; Solá, S.; Silva, R.; Brites, D. Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol. Med. 2000, 6, 936-946.
118. Rodrigues, C.M.; Sola, S.; Sharpe, J.C.; Moura, J.J.; Steer, C.J. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry 2003, 42, 3070-3080.
119. Ozcan, L.; Ergin, A.S.; Lu, A.; Chung, J.; Sarkar, S.; Nie, D.; Myers, M.G.; Ozcan, U. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009, 9, 35-51.
120. Malo, A.; Krüger, B.; Seyhun, E.; Schäfer, C.; Hoffmann, R.T.; Göke, B.; Kubisch, C.H. Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, trypsin activation, and acinar cell apoptosis while increasing secretion in rat pancreatic acini. Am. J. Physiol. 2010, 299, G877-G886.
121. Duricka, D.L.; Brown, R.L.; Varnum, M.D. Defective trafficking of cone photoreceptor CNG channels induces the unfolded protein response and ER-stress-associated cell death. Biochem. J. 2012, 441, 685-696.
122. Xie, Q.; Khaoustov, V.I.; Chung, C.C.; Sohn, J.; Krishnan, B.; Lewis, D.E.; Yoffe, B. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 2002, 36, 592-601.
123. Herrero-Vanrell, R.; Cardillo, J.A.; Kuppermann, B.D. Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin. Ophthalmol. 2011, 5, 139-146.